APA (7th ed.) Citation

E, C., J, F., S, S., A, R., M, J., C, D., . . . A, K. (2024). Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders. Haematologica, 109(4), 1137. https://doi.org/10.3324/haematol.2023.283295

Chicago Style (17th ed.) Citation

E, Cournoyer, et al. "Dabrafenib and Trametinib in Langerhans Cell Histiocytosis and Other Histiocytic Disorders." Haematologica 109, no. 4 (2024): 1137. https://doi.org/10.3324/haematol.2023.283295.

MLA (9th ed.) Citation

E, Cournoyer, et al. "Dabrafenib and Trametinib in Langerhans Cell Histiocytosis and Other Histiocytic Disorders." Haematologica, vol. 109, no. 4, 2024, p. 1137, https://doi.org/10.3324/haematol.2023.283295.